Clinical characteristics and risk factors associated with mortality in patients with severe community-acquired pneumonia and type 2 diabetes mellitus
- PMID: 34876193
- PMCID: PMC8650350
- DOI: 10.1186/s13054-021-03841-w
Clinical characteristics and risk factors associated with mortality in patients with severe community-acquired pneumonia and type 2 diabetes mellitus
Abstract
Background: The present study was performed to investigate the impacts of type 2 diabetes mellitus (T2DM) on severe community-acquired pneumonia (SCAP) and to develop a novel prediction model for mortality in SCAP patients with T2DM.
Methods: This was a retrospective observational study conducted in consecutive adult patients with SCAP admitted to the intensive care unit (ICU) of West China Hospital, Sichuan University, China, between September 2011 and September 2019. The primary outcome was hospital mortality. A propensity score matching (PSM) analysis model with a 1:2 ratio was used for the comparisons of clinical characteristics and outcomes between T2DM and nondiabetic patients. The independent risk factors were identified via univariate and then multivariable logistic regression analysis and were then used to establish a nomogram.
Results: In total, 1262 SCAP patients with T2DM and 2524 matched patients without T2DM were included after PSM. Patients with T2DM had longer ICU length of stay (LOS) (13 vs. 12 days, P = 0.016) and higher 14-day mortality (15% vs. 10.8%, P < 0.001), 30-day mortality (25.7% vs. 22.7%, P = 0.046), ICU mortality (30.8% vs. 26.5%, P = 0.005), and hospital mortality (35.2% vs. 31.0%, P = 0.009) than those without T2DM. In SCAP patients with T2DM, the independent risk factors for hospital mortality were increased numbers of comorbidities and diabetes-related complications; elevated C-reactive protein (CRP), neutrophil to lymphocyte ratio (NLR), brain natriuretic peptide (BNP) and blood lactate; as well as decreased blood pressure on admission. The nomogram had a C index of 0.907 (95% CI: 0.888, 0.927) in the training set and 0.873 (95% CI: 0.836, 0.911) in the testing set, which was superior to the pneumonia severity index (PSI, AUC: 0.809, 95% CI: 0.785, 0.833). The calibration curve and decision curve analysis (DCA) also demonstrated its accuracy and applicability.
Conclusions: SCAP patients with T2DM had worse clinical outcomes than nondiabetic patients. The nomogram has good predictive performance for hospital mortality and might be generally applied after more external validations.
Keywords: Clinical characteristics; Nomogram; Risk factors; Severe community-acquired pneumonia; Type 2 diabetes mellitus.
© 2021. The Author(s).
Conflict of interest statement
The authors declare that they have no competing interests.
Figures







Similar articles
-
Incidence and risk factor of sepsis in patients with severe community-acquired pneumonia: a Chinese, single-center, retrospective study.BMC Infect Dis. 2025 May 2;25(1):649. doi: 10.1186/s12879-025-11027-w. BMC Infect Dis. 2025. PMID: 40316949 Free PMC article.
-
A prediction model for hospital mortality in patients with severe community-acquired pneumonia and chronic obstructive pulmonary disease.Respir Res. 2022 Sep 18;23(1):250. doi: 10.1186/s12931-022-02181-9. Respir Res. 2022. PMID: 36117161 Free PMC article.
-
[Timing of sequential noninvasive mechanical ventilation following early extubation in aged patients with severe community-acquired pneumonia].Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2020 Mar;32(3):324-329. doi: 10.3760/cma.j.cn121430-20191224-00072. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2020. PMID: 32385997 Chinese.
-
Validation and comparison of SCAP as a predictive score for identifying low-risk patients in community-acquired pneumonia.J Infect. 2010 Feb;60(2):106-13. doi: 10.1016/j.jinf.2009.11.013. Epub 2009 Dec 2. J Infect. 2010. PMID: 19961875 Review.
-
Towards a sensible comprehension of severe community-acquired pneumonia.Intensive Care Med. 2011 Feb;37(2):214-23. doi: 10.1007/s00134-010-2077-0. Epub 2010 Nov 16. Intensive Care Med. 2011. PMID: 21080155 Review.
Cited by
-
Clinical characteristics and pathogen analysis of bronchoalveolar lavage fluid in elderly patients with community-acquired pneumonia.Immun Inflamm Dis. 2023 Apr;11(4):e813. doi: 10.1002/iid3.813. Immun Inflamm Dis. 2023. PMID: 37102644 Free PMC article.
-
Differential impact of neutrophil-to-lymphocyte ratio and time-weighted NLR on mortality and survival in critically ill children: insights from a retrospective study.Front Pediatr. 2025 May 20;13:1559405. doi: 10.3389/fped.2025.1559405. eCollection 2025. Front Pediatr. 2025. PMID: 40464042 Free PMC article.
-
Machine learning-based model for predicting all-cause mortality in severe pneumonia.BMJ Open Respir Res. 2025 Mar 22;12(1):e001983. doi: 10.1136/bmjresp-2023-001983. BMJ Open Respir Res. 2025. PMID: 40122535 Free PMC article.
-
Development and Validation of a Risk Mortality Prediction Model for Patients with Pulmonary Tuberculosis Complicated by Severe Community-Acquired Pneumonia in the Intensive Care Unit.Infect Drug Resist. 2024 Jul 17;17:3113-3124. doi: 10.2147/IDR.S459290. eCollection 2024. Infect Drug Resist. 2024. PMID: 39050825 Free PMC article.
-
Changes in inflammatory markers and efficacy analysis of continuous subcutaneous insulin infusion in senior patients with type 2 diabetes mellitus hospitalized with community-acquired pneumonia: a randomized controlled trial.Eur Geriatr Med. 2024 Apr;15(2):519-525. doi: 10.1007/s41999-023-00915-6. Epub 2024 Jan 9. Eur Geriatr Med. 2024. PMID: 38194052 Clinical Trial.
References
-
- Metlay JP, Waterer GW, Long AC, et al. Diagnosis and treatment of adults with community-acquired pneumonia. An official clinical practice guideline of the American Thoracic Society and Infectious Diseases Society of America. Am J Respir Crit Care Med. 2019;200(7):e45–e67. doi: 10.1164/rccm.201908-1581ST. - DOI - PMC - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous